Medicines Marketed by Bliss Gvs Pharma Limited

About Bliss GVS Pharma Limited

Bliss GVS Pharma Limited is a prominent player in the pharmaceutical sector, specialising in the development, manufacture, and marketing of a wide range of pharmaceutical formulations. Established in 1984 as Bliss Chemicals and Pharmaceuticals India Limited, the company underwent a takeover by GVS Lab in 2006, leading to its current name. With its headquarters in Mumbai, India, Bliss GVS Pharma Limited has expanded its reach to over 60 countries worldwide.

Bliss GVS Pharma Limited caters to a diverse global consumer base, with a strong presence in Africa where it holds a leadership position in the anti-malarial segment. The company's extensive manufacturing and marketing capabilities enable it to effectively address various therapeutic needs across different regions, solidifying its position as a key player in the international pharmaceutical market.

Bliss GVS Pharma Limited Products

Bliss GVS Pharma Limited offers a comprehensive portfolio of pharmaceutical formulations across multiple dosage forms, including suppositories, pessaries, capsules, tablets, syrups, dry syrups, nasal sprays, ampules, eye, ear, and nose drops, as well as injections, including dry powder formulations for injections. The company's products span a wide range of therapeutic categories, such as anti-fungal, contraceptive, laxative, anti-haemorrhoidal, anti-spasmodic, anti-malarial, anti-biotic, anti-microbial, anti-inflammatory, antipyretic, analgesic, and anti-diabetic.

Renowned for its expertise in anti-malarial products, particularly those based on Artemisinin combinations, Bliss GVS Pharma Limited offers these in various dosage forms, including tablets, suspensions, sachets, suppositories, and injections. Bliss GVS Pharma Limited's commitment to innovation and adherence to international manufacturing standards, such as EU GMP, WHO GMP, OHSAS-18001:2007, and ISO-14001:2004, sets it apart in the market, ensuring the delivery of high-quality and reliable pharmaceutical products to its global consumer base.